Description
Lila Biologics, Inc. is pioneering the translation of AI-designed proteins into therapeutic applications with enormous potential to improve patient outcomes. Together at Lila, they are boldly defining the future of next-generation protein therapeutics for both oncology and non-oncology indications.
Team Members
Jake Kraft
CEO
Anindya Roy
CSO